Journal of Nursing ›› 2025, Vol. 32 ›› Issue (1): 1-6.doi: 10.16460/j.issn1008-9969.2025.01.001
LIU Qi1, LIU Jia-li2a, LIU Yu2a, YANG Li-min3, FAN Yu-ying2b, LV Xing2b, JIN Hui-ying2a
CLC Number:
[1] Hong RL, Hsiao CF, Ting LL, et al.Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study[J]. Ann Oncol, 2018, 29(9):1972-1979.DOI:10.1093/annonc/mdy249. [2] Yao JJ, Zhang F, Gao TS, et al.Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data intelligence platform-based analysis[J]. Radiother Oncol, 2019, 132:178-187.DOI:10.1016/j.radonc.2018.10.018. [3] Armstrong TS.Symptoms experience: a concept analysis[J]. Oncol Nurs Forum, 2003, 30(4):601-606. DOI:10.1188/03.ONF.601-606. [4] 刘源,骆方,刘红云.多阶段混合增长模型的影响因素:距离与形态[J].心理学报,2014, 46(9):1400-1412.DOI:10.3724/SP.J.1041.2014.01400. [5] Jordan JE, Buchbinder R, Briggs AM, et al.The Health Literacy Management Scale (HeLMS): a measure of an individual's capacity to seek, understand and use health information within the healthcare setting[J]. Patient Educ Couns, 2013, 91(2):228-235.DOI:10.1016/j.pec. 2013.01.013. [6] 孙浩林,彭慧,傅华.慢性病患者健康素养量表信效度的研究[J].复旦学报(医学版), 2012, 39(3):268-272.DOI:10.3969/j.issn.1672-8467.2012.03.009. [7] Antonovsky A.The structure and properties of the Sense of Coherence Scale[J]. Soc Sci Med, 1993, 36(6):725-733.DOI:10.1016/0277-9536(93)90033-Z. [8] 包蕾萍,刘俊升.心理一致感量表(SOC-13)中文版的修订[J].中国临床心理学杂志,2005, 13(4):399-401.DOI:10.3969/j.issn.1005-3611.2005.04.007. [9] Basch E, Reeve BB, Mitchell SA, et al.Development of the national cancer institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. J Natl Cancer Inst, 2014,106(9):244.DOI:10.1093/jnci/dju244. [10] Kkf C, Mitchell SA, Chan N, et al.Linguistic validation of the simplified Chinese version of the US national cancer institute's Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAETM)[J]. BMC Cancer, 2020, 20(1): 1153.DOI:10.1186/s12885-020-07631-5. [11] Basch E, Becker C, Rogak LJ, et al.Composite grading algorithm for the national cancer institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. Clin Trials, 2021, 18(1):104-114.DOI:10.1177/1740774520975120. [12] Oswald LB, Gudenkauf LM, Li XY, et al.Patient-reported outcomes among multiple myeloma patients treated with standard of care idecabtagene vicleucel[J]. Cancers, 2023, 15(19):4711.DOI:10.3390/cancers15194711. [13] Tang LL, Chen YP, Chen CB, et al.The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma[J]. Cancer Commun, 2021, 41(11):1195-1227.DOI:10.1002/cac2.12218. [14] 丁凤琴,田晶,孟冰霞,等.潜变量增长混合模型在慢性心衰患者生理症状变化轨迹研究中的应用[J].中国卫生统计,2023, 40(4):482-486.DOI:10.11783/j.issn.1002-3674.2023.04.001. [15] 陈坚,王园,崔艳丽,等.缺血性脑卒中后吞咽障碍患者经口摄食功能发展轨迹及影响因素分析[J].护理学报, 2023, 30(24):1-6. DOI:10.16460/j.issn1008-9969.2023.24.001. [16] 黄珂瑶,丁思妍,周海琴,等.肺移植患者衰弱变化轨迹及影响因素研究[J].中华护理杂志, 2023, 58(9):1088-1095.DOI:10.3761/j.issn.0254-1769.2023.09.010. [17] Dunnack YH, Xu W, Lee JW, et al.Symptom patterning across the cancer care trajectory for patients receiving chemoradiation for head and neck cancer: a retrospective longitudinal study using latent transition analysis[J]. Cancer Nurs, 2023.DOI: 10.1097/NCC.0000000000001227. Online ahead of print. [18] Wang CH, Chen JM, Su L, et al.The psychological status in patients with nasopharyngeal carcinoma during radiotherapy[J]. Eur Arch Oto-Rhino-L, 2022, 279(2):1035-1042.DOI: 10.1007/s00405-021-06892-5. [19] Burns M, Campbell R, French S, et al.Trajectory of anxiety related to radiation therapy mask immobilization and treatment delivery in head and neck cancer and radiation therapists? Ability to detect this anxiety[J]. Adv Radiat Oncol, 2022, 7(5):100967.DOI: 10.1016/j.adro.2022.100967. [20] Mcfarland DC, Doherty M, Atkinson TM, et al.Cancer-related inflammation and depressive symptoms: systematic review and Meta-analysis[J].Cancer-Am Cancer Soc, 2022, 128(13): 2504-2519.DOI:10.1002/cncr.34193. [21] Person H, Keefer L.Psychological comorbidity in gastrointestinal diseases: update on the brain-gut-microbiome axis[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2021, 107: 110209.DOI:10.1016/j.pnpbp.2020.110209. [22] Tsuji D, Suzuki K, Kawasaki Y, et al.Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial[J]. Support Care Cancer, 2019, 27(3):1139-1147.DOI:10.1007/s00520-018-4403-y. [23] Wong ML, Paul SM, Cooper BA, et al.Predictors of the multidimensional symptom experience of lung cancer patients receiving chemotherapy[J].Support Care Cancer, 2017, 25(6):1931-1939.DOI:10.1007/s00520-017-3593-z. [24] Grevenstein D, Aguilar RC, Schweitzer J, et al.Through the tunnel, to the light: why sense of coherence covers and exceeds resilience, optimism, and self-compassion[J]. Pers Indiv Differ,2016, 98:208-217.DOI:10.1016/j.paid.2016.04.001. |
|